These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29551465)

  • 1. The possible role of maintenance treatment for primary central nervous system lymphoma.
    Bairey O; Siegal T
    Blood Rev; 2018 Sep; 32(5):378-386. PubMed ID: 29551465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches in primary central nervous system lymphoma.
    Fraser E; Gruenberg K; Rubenstein JL
    Chin Clin Oncol; 2015 Mar; 4(1):11. PubMed ID: 25841718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving Treatments for Primary Central Nervous System Lymphoma.
    Ferreri AJM; Holdhoff M; Nayak L; Rubenstein JL
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():454-466. PubMed ID: 31099614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system lymphoma: essential points in diagnosis and management.
    Paydas S
    Med Oncol; 2017 Apr; 34(4):61. PubMed ID: 28315229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of primary central nervous system lymphoma.
    Han CH; Batchelor TT
    Cancer; 2017 Nov; 123(22):4314-4324. PubMed ID: 28950405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
    Bierman P; Giglio P
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.
    Langner-Lemercier S; Houillier C; Soussain C; Ghesquières H; Chinot O; Taillandier L; Soubeyran P; Lamy T; Morschhauser F; Benouaich-Amiel A; Ahle G; Moles-Moreau MP; Moluçon-Chabrot C; Bourquard P; Damaj G; Jardin F; Larrieu D; Gyan E; Gressin R; Jaccard A; Choquet S; Brion A; Casasnovas O; Colin P; Reman O; Tempescul A; Marolleau JP; Fabbro M; Naudet F; Hoang-Xuan K; Houot R
    Neuro Oncol; 2016 Sep; 18(9):1297-303. PubMed ID: 26951382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary central nervous system lymphomas].
    Hrudková M; Belada D; Smolej L; Zák P; Malý J
    Vnitr Lek; 2010 Aug; 56(8):795-800. PubMed ID: 20845611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical presentation of primary central nervous system non-Hodgkin lymphoma in immunocompetent young adults.
    Cheatle JT; Aizenberg MR; Weinberg JS; Surdell DL
    World Neurosurg; 2013; 79(3-4):593.e9-13. PubMed ID: 22885166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of primary central nervous system lymphoma.
    Ekenel M; DeAngelis LM
    Curr Neurol Neurosci Rep; 2007 May; 7(3):191-9. PubMed ID: 17488584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary central nervous system lymphoma.
    Gerstner ER; Batchelor TT
    Arch Neurol; 2010 Mar; 67(3):291-7. PubMed ID: 20212226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary central nervous system lymphoma: overview of current treatment strategies.
    Brastianos PK; Batchelor TT
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):897-916. PubMed ID: 22794289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and opportunities in primary CNS lymphoma: A systematic review.
    Kerbauy MN; Moraes FY; Lok BH; Ma J; Kerbauy LN; Spratt DE; Santos FP; Perini GF; Berlin A; Chung C; Hamerschlak N; Yahalom J
    Radiother Oncol; 2017 Mar; 122(3):352-361. PubMed ID: 28104300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features and treatment outcomes in primary central nervous system lymphoma: a descriptive analysis of 62 patients].
    Ge Y; Lin XT; Luo DL; Zhang F; Xu J; Li Z; Liu YH
    Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):861-866. PubMed ID: 31775435
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary central nervous system lymphoma: advances in treatment strategies].
    Kondo E
    Rinsho Ketsueki; 2020; 61(5):510-519. PubMed ID: 32507817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in the management of primary central nervous system lymphoma.
    Sun X; Lv L; Wu Y; Cui Q; Sun S; Ji N; Liu Y
    Crit Rev Oncol Hematol; 2023 Aug; 188():104042. PubMed ID: 37277008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary central nervous system lymphoma: Novel precision therapies.
    Mondello P; Mian M; Bertoni F
    Crit Rev Oncol Hematol; 2019 Sep; 141():139-145. PubMed ID: 31295667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary CNS lymphoma in immunocompetent patients.
    Sierra del Rio M; Rousseau A; Soussain C; Ricard D; Hoang-Xuan K
    Oncologist; 2009 May; 14(5):526-39. PubMed ID: 19433528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review).
    Liu Y; Yao Q; Zhang F
    Int J Oncol; 2021 Mar; 58(3):371-387. PubMed ID: 33650642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.